Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_assertion type Assertion NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_head.
- NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_assertion description "[The effect of 5 to 9 days of metyrapone administration (400 mg/m2 every 4 h) on aldosterone, deoxycorticosterone, plasma renin activity, electrolyte balance, and blood pressure was investigated in 2 normotensive siblings (one of whom showed limited ACTH reserve), in 3 patients with hypertension and dexamethasone-suppressible hyperaldosteronism, and in a hypertensive patient with primary hyperaldosteronism due to bilateral adrenal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_provenance.
- NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_assertion evidence source_evidence_literature NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_provenance.
- NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_assertion SIO_000772 7025545 NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_provenance.
- NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_assertion wasDerivedFrom befree-2016 NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_provenance.
- NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_assertion wasGeneratedBy ECO_0000203 NP1307493.RA2L5qO1t9hpIJaCopL-QOeaSJaudEc1JBzRyfjVFlNQc130_provenance.